SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-219173
Filing Date
2020-08-13
Accepted
2020-08-13 16:26:02
Documents
14
Period of Report
2020-08-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d63167d8k.htm   iXBRL 8-K 30442
2 EX-99.1 d63167dex991.htm EX-99.1 15525
6 GRAPHIC g63167g58q24.jpg GRAPHIC 5070
  Complete submission text file 0001193125-20-219173.txt   180139

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mygn-20200813.xsd EX-101.SCH 3064
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20200813_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20200813_pre.xml EX-101.PRE 10949
7 EXTRACTED XBRL INSTANCE DOCUMENT d63167d8k_htm.xml XML 3274
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 201099691
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences